PortfoliosLab logoPortfoliosLab logo
ISIN
US03763A2078
CUSIP
03763A108
IPO Date
Jan 13, 2000

Highlights

Market Cap
$1.80B
Enterprise Value
$1.46B
EPS (TTM)
$0.61
PE Ratio
59.95
Total Revenue (TTM)
$3.53B
Gross Profit (TTM)
$238.21M
EBITDA (TTM)
$125.28M
Year Range
$18.08 - $39.93
Target Price
$34.20
ROA (TTM)
1.28%
ROE (TTM)
3.78%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Astrana Health Inc

Performance

ASTH Performance Chart

Astrana Health Inc (ASTH) is up 47.9% since the beginning of the year. At $37 per share, ASTH is trading 8.1% below its 52-week high of $40. Investors who bought $1,000 worth of ASTH shares 5 years ago would now be looking at an investment worth $994.


Loading charts...

S&P 500 Index

Returns By Period

Astrana Health Inc (ASTH) has returned 47.92% so far this year and 45.69% over the past 12 months. Looking at the last ten years, ASTH has achieved an annualized return of 20.92%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.


Astrana Health Inc

1D
-0.57%
1M
4.92%
YTD
47.92%
6M
59.43%
1Y
45.69%
3Y*
2.84%
5Y*
-0.12%
10Y*
20.92%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASTH Monthly Returns History

Based on dividend-adjusted daily data since Feb 23, 2011, ASTH's average daily return is +0.64%, while the average monthly return is +10.45%. At this rate, an investment would double in approximately 0.6 years.

Historically, 46% of months were positive and 54% were negative. The best month was Apr 2015 with a return of +900.0%, while the worst month was Nov 2016 at -64.8%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ASTH closed higher 36% of trading days. The best single day was Apr 29, 2015 with a return of +1,011.1%, while the worst single day was Nov 30, 2016 at -63.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-8.34%-10.60%20.61%39.23%10.19%-2.45%47.92%
202516.94%-31.16%22.18%0.52%-20.47%0.36%-4.10%33.95%-11.30%10.09%-26.18%7.68%-21.31%
2024-9.27%29.61%-6.77%-11.53%11.52%-2.10%29.34%-8.90%21.24%-7.18%-19.58%-27.10%-17.68%
202320.45%-2.08%4.50%-2.69%-10.90%-0.06%15.92%3.36%-18.52%1.17%6.47%15.26%29.44%
2022-29.94%-6.53%0.73%-24.74%2.91%2.80%37.42%-18.67%-9.58%-9.08%-19.74%3.97%-59.73%
202120.42%12.50%9.45%9.60%17.48%80.07%40.69%-14.10%19.94%-24.62%36.49%-21.55%302.19%

Benchmark Metrics

Astrana Health Inc has an annualized alpha of 351.82%, beta of 0.70, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 24, 2011.

  • This stock captured 211.25% of S&P 500 Index gains but only 87.95% of its losses - a favorable profile for investors.
  • Beta of 0.70 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
351.82%
Beta
0.70
0.00
Upside Capture
211.25%
Downside Capture
87.95%

Return for Risk

Risk / Return Rank

ASTH ranks 63 for risk / return — better than 63% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


ASTH Risk / Return Rank: 6363
Overall Rank
ASTH Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
ASTH Sortino Ratio Rank: 6262
Sortino Ratio Rank
ASTH Omega Ratio Rank: 6666
Omega Ratio Rank
ASTH Calmar Ratio Rank: 6262
Calmar Ratio Rank
ASTH Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Astrana Health Inc (ASTH) and compare them to S&P 500 Index.


ASTHBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.61

Sortino ratioReturn per unit of downside risk

-1.73

Omega ratioGain probability vs. loss probability

1.20

1.41

-0.20

Calmar ratioReturn relative to maximum drawdown

0.99

2.93

-1.94

Martin ratioReturn relative to average drawdown

2.19

13.52

-11.33

Dividends

Dividend History


Astrana Health Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Astrana Health Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Astrana Health Inc was 84.80%, occurring on Feb 12, 2026. The portfolio has not yet recovered.

The current Astrana Health Inc drawdown is 69.28%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-84.80%Feb 2026
4y 2mo
4y 6moNov 2021 - now
2016 bear market2016
-83.35%Nov 2016
1y 3mo1mo 7d
1y 4moAug 2015 - Jan 2017
2014 bear market2014
-78.26%Oct 2014
1y 10mo6mo 4d
2y 4moDec 2012 - Apr 2015
2011 bear market2011
-76.82%Dec 2011
8mo 20d7mo 3d
1y 3moMar 2011 - Jul 2012
2012 bear market2012
-68.25%Aug 2012
24d3mo 27d
4mo 21dJul 2012 - Dec 2012

Drawdown Indicators


ASTHBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-84.80%

-56.78%

-28.02%

Max Drawdown (1Y)

Largest decline over 1 year

-46.41%

-9.10%

-37.31%

Max Drawdown (3Y)

Largest decline over 3 years

-70.96%

-18.90%

-52.06%

Max Drawdown (5Y)

Largest decline over 5 years

-84.80%

-25.43%

-59.37%

Max Drawdown (10Y)

Largest decline over 10 years

-84.80%

-33.92%

-50.88%

Current Drawdown

Current decline from peak

-69.28%

-0.74%

-68.54%

Average Drawdown

Average peak-to-trough decline

-47.09%

-10.72%

-36.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.93%

1.97%

+18.96%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Astrana Health Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Astrana Health Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ASTH, comparing it with other companies in the Medical Care Facilities industry. Currently, ASTH has a P/E ratio of 59.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ASTH relative to other companies in the Medical Care Facilities industry. Currently, ASTH has a P/S ratio of 0.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ASTH in comparison with other companies in the Medical Care Facilities industry. Currently, ASTH has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ASTH

Add Astrana Health Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ASTH